Fig. 4 | Scientific Reports

Fig. 4

From: Minocycline alleviates lipopolysaccharide-induced cardiotoxicity by suppressing the NLRP3/Caspase-1 signaling pathway

Fig. 4

Minocycline attenuated LPS-induced H9c2 cell injury. (A) Chemical structure of minocycline. (B) Cells were treated with 0–160 μM Min for 24 h, and cell viability was detected by the CCK-8 assay. (C) LDH level was measured in Min-treated H9c2 cells. (D) Min improved cell viability in LPS-treated H9c2 cells. (E) Min decreased LDH release in LPS-treated H9c2 cells. Data were presented as mean ± SD; n = 3; *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. LPS group.

Back to article page